PT1879609E - Utilização de histionas para fins terapêuticos - Google Patents

Utilização de histionas para fins terapêuticos Download PDF

Info

Publication number
PT1879609E
PT1879609E PT67427922T PT06742792T PT1879609E PT 1879609 E PT1879609 E PT 1879609E PT 67427922 T PT67427922 T PT 67427922T PT 06742792 T PT06742792 T PT 06742792T PT 1879609 E PT1879609 E PT 1879609E
Authority
PT
Portugal
Prior art keywords
histones
therapeutic purposes
therapeutic
purposes
Prior art date
Application number
PT67427922T
Other languages
English (en)
Inventor
Michael Zeppezauer
Class Reiner
Original Assignee
Symbiotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbiotec Gmbh filed Critical Symbiotec Gmbh
Publication of PT1879609E publication Critical patent/PT1879609E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT67427922T 2005-05-10 2006-05-04 Utilização de histionas para fins terapêuticos PT1879609E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005022319A DE102005022319A1 (de) 2005-05-10 2005-05-10 Verwendung von Histonen zu therapeutischen Zwecken

Publications (1)

Publication Number Publication Date
PT1879609E true PT1879609E (pt) 2014-06-09

Family

ID=37310925

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67427922T PT1879609E (pt) 2005-05-10 2006-05-04 Utilização de histionas para fins terapêuticos

Country Status (12)

Country Link
US (3) US20090305966A1 (pt)
EP (1) EP1879609B1 (pt)
JP (2) JP2008540473A (pt)
KR (3) KR20130099207A (pt)
CN (1) CN101171027A (pt)
CA (2) CA2608019C (pt)
DE (1) DE102005022319A1 (pt)
ES (1) ES2461564T3 (pt)
HU (1) HUE027070T2 (pt)
PL (1) PL1879609T3 (pt)
PT (1) PT1879609E (pt)
WO (1) WO2006119912A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022319A1 (de) * 2005-05-10 2006-11-23 Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh Verwendung von Histonen zu therapeutischen Zwecken

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
AU3834589A (en) * 1988-05-31 1990-01-05 Schering Biotech Corporation Method of treating myeloid leukemias
DE4000154A1 (de) * 1990-01-04 1991-07-11 Symbiotec Gmbh Chemotherapeutisches mittel, insbesondere zur behandlung von krebserkrankungen
US5571686A (en) * 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
US20030017987A1 (en) * 1997-04-11 2003-01-23 Michael Zeppezauer Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
DE19715149A1 (de) * 1997-04-11 1998-10-15 Symbiotec Gmbh Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft
US6884423B1 (en) * 1998-08-13 2005-04-26 Symbiotec Gmbh Antimicrobial histone H1 compositions, kits, and methods of use thereof
AU4676500A (en) * 1999-04-28 2000-11-10 Northwestern University Localization of major peptide autoepitopes for nucleosome specific t cells of systemic lupus erythematosus
DE10001113A1 (de) * 2000-01-13 2001-07-26 Strathmann Ag & Co Rekombinante Herstellung von humanen Histon 1-Subtypen sowie deren Verwendung für therapeutische Zwecke
EP1364657B1 (en) 2001-02-07 2016-12-28 Chugai Seiyaku Kabushiki Kaisha Remedies for myelocytic leukemia
WO2002067907A1 (en) 2001-02-22 2002-09-06 Philadelphia, Health And Education Corporation Compositions and methods for preventing platelet aggregation
JP2002355048A (ja) * 2001-05-31 2002-12-10 Communication Research Laboratory リボヌクレオチド還元酵素ｒ１とその阻害ペプチド
DE10230223A1 (de) * 2002-07-04 2004-01-22 Tegenero Ag Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern
US20040146585A1 (en) * 2002-10-31 2004-07-29 Oregon Health & Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
DE102005022319A1 (de) * 2005-05-10 2006-11-23 Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh Verwendung von Histonen zu therapeutischen Zwecken

Also Published As

Publication number Publication date
US20150119331A1 (en) 2015-04-30
KR20140137462A (ko) 2014-12-02
JP5667238B2 (ja) 2015-02-12
US20090305966A1 (en) 2009-12-10
CA2811995A1 (en) 2006-11-16
EP1879609A2 (de) 2008-01-23
CA2608019A1 (en) 2006-11-16
KR20130099207A (ko) 2013-09-05
WO2006119912A3 (de) 2007-04-12
HUE027070T2 (en) 2016-08-29
DE102005022319A1 (de) 2006-11-23
ES2461564T3 (es) 2014-05-20
US8962562B2 (en) 2015-02-24
JP2008540473A (ja) 2008-11-20
US20140148391A1 (en) 2014-05-29
EP1879609B1 (de) 2014-03-12
KR20080007351A (ko) 2008-01-18
CN101171027A (zh) 2008-04-30
JP2013151573A (ja) 2013-08-08
WO2006119912A2 (de) 2006-11-16
PL1879609T3 (pl) 2014-08-29
CA2608019C (en) 2013-07-02

Similar Documents

Publication Publication Date Title
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
HK1211889A1 (en) Therapeutic use of diaminophenothiazines
PT3424932T (pt) Boronoftalidas para utilização terapêutica
GB0625659D0 (en) Therapeutic compounds and their use
EP2068864A4 (en) THERAPEUTIC USES OF UROLITHINS
IL193747A0 (en) New therapeutic combinations for the treatment of depression
GB0506835D0 (en) Therapeutic use of nefopam
HK1161122A1 (en) Use of 24-norudca 24-norudca
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0501655D0 (en) Therapeutic use
GB0515703D0 (en) Therapeutic use of nefopam
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
EP1908467A4 (en) HERPESVIRUS DERIVED THERAPEUTIC AGENTS AGAINST PAIN
PT1879609E (pt) Utilização de histionas para fins terapêuticos
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
GB0614538D0 (en) Therapeutic Compounds And Their Use
GB0602857D0 (en) The treatment of sialorrhoea
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
IL195722A0 (en) Therapeutic uses of inhibitors of rtp801l
GB0625633D0 (en) Therapeutic compounds and their use
GB0518003D0 (en) Treatment of hepatatis c
GB0518537D0 (en) Therapeutic use
GB0501657D0 (en) Therapeutic use
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis
GB0602855D0 (en) The Treatment Of Sialorrhoea